Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients.

@article{Benhamou1999LongtermIO,
  title={Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients.},
  author={Yves Benhamou and M Bochet and Vincent Thibault and Vincent Di Martino and {\'E}ric Caumes and François Bricaire and Pierre Opolon and Christine Katlama and Thierry Poynard},
  journal={Hepatology},
  year={1999},
  volume={30 5},
  pages={1302-6}
}
Hepatitis B virus (HBV) resistance to lamivudine has not been extensively documented in human immunodeficiency virus (HIV)-infected patients. We studied the long-term incidence of HBV resistance to lamivudine in HIV-positive patients. Sixty-six HIV-HBV-coinfected patients were studied while receiving lamivudine (150 mg twice daily) as a part of antiretroviral therapy. All these patients had a detectable serum HBV DNA at the beginning of lamivudine therapy. Serum HBV DNA was quantified by… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 144 extracted citations

Similar Papers

Loading similar papers…